Product image of Moxonidine Teva (Moxonidine) supplied by GNH India

Moxonidine Teva

Active Ingredient:
Moxonidine
Origin:
EU

Moxonidine Teva (Moxonidine)

Moxonidine, the active ingredient in Moxonidine Teva, is an imidazoline receptor agonist presented as an oral tablet for systemic use. It selectively lowers elevated blood pressure by reducing sympathetic nervous system activity and is indicated for the treatment of hypertension in adult patients.

GNH India supplies Moxonidine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including temperature‑controlled shipping where required.

Manufacturer / TM Owner

Teva B.V

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Moxonidine is used in the management of elevated arterial pressure by stimulating central imidazoline I1 receptors, which leads to reduced sympathetic outflow.
  • Hypertension: lowers both systolic and diastolic blood pressure, helping achieve guideline‑recommended targets in adult patients.
  • Essential hypertension: provides effective blood pressure control as monotherapy or in combination with other antihypertensives.
  • Resistant hypertension (adjunct): may be added when blood pressure remains uncontrolled despite use of at least three antihypertensive agents.

How It Works

  • Moxonidine selectively activates central imidazoline I1 receptors located in the rostral ventrolateral medulla. Stimulation of these receptors diminishes sympathetic nervous system outflow, leading to decreased peripheral vascular resistance, reduced heart rate, and lowered renin release, which collectively result in a reduction of arterial blood pressure. The drug’s action does not involve direct adrenergic blockade, which contributes to a favorable side‑effect profile compared with some older antihypertensives.

Side Effects

Moxonidine may be associated with a range of adverse reactions, which are generally classified by frequency.

Common Side Effects

  • Dry mouth: sensation of oral dryness.
  • Dizziness: light‑headedness, especially on standing.
  • Fatigue: feeling of tiredness or reduced energy.
  • Headache: mild to moderate cranial pain.
  • Nausea: upset stomach, occasional vomiting.

Serious or Rare Side Effects

  • Severe hypotension: marked drop in blood pressure causing fainting.
  • Bradycardia: abnormally low heart rate requiring medical attention.
  • Hepatic dysfunction: elevated liver enzymes or hepatitis.
  • Allergic reactions: rash, itching, swelling, or anaphylaxis.

Precautions & Warnings

  • When prescribing Moxonidine, clinicians should consider several precautionary measures to ensure safe use.
  • Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension.
  • Renal impairment: dose adjustment may be required in patients with reduced kidney function.
  • Hepatic disease: use cautiously and monitor liver function tests.
  • Elderly patients: start at lower dose due to increased sensitivity.
  • Concomitant antihypertensives: assess risk of additive blood pressure lowering.
  • Store at room temperature: keep in original packaging, protect from moisture and heat.

Avoid Interactions

Moxonidine can interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid)

  • Combined use with other central sympatholytics (e.g., clonidine) may cause profound hypotension.
  • Concurrent administration with potent CYP2D6 inhibitors can increase plasma levels, raising risk of adverse effects.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: additive effect on heart rate and blood pressure, monitor vitals.
  • Diuretics: may enhance antihypertensive effect, adjust dose as needed.
  • NSAIDs: can attenuate antihypertensive response, observe blood pressure control.

Frequently Asked Questions

Moxonidine Teva is prescribed for the treatment of hypertension. By reducing sympathetic nervous system activity, it helps lower both systolic and diastolic blood pressure, supporting patients in reaching recommended blood‑pressure targets.

Moxonidine selectively stimulates central imidazoline I1 receptors in the brainstem. This activation dampens sympathetic outflow, leading to decreased peripheral vascular resistance, lower heart rate, and reduced renin release, which together lower arterial blood pressure.

The exact dose of Moxonidine Teva is determined by the prescribing clinician based on the individual’s blood‑pressure profile, age, renal function and concomitant therapies. Typically, treatment starts at a low dose and is titrated to achieve optimal control.

Safety data for Moxonidine in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It is generally recommended to avoid use unless the potential benefit justifies the potential risk to the fetus or infant.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moxonidine differs from traditional agents such as ACE inhibitors or beta‑blockers by targeting central imidazoline I1 receptors rather than the renin‑angiotensin system or adrenergic receptors. This mechanism can result in fewer metabolic side effects, but clinicians still consider individual patient profiles when choosing therapy.

Moxonidine tablets should be stored at room temperature, below 25 °C, in the original container. Protect them from moisture, direct sunlight and excessive heat to maintain product stability throughout its shelf life.

Moxonidine is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescriber’s instructions regarding timing and whether the dose should be taken in the morning or evening.

The most serious adverse events to monitor are severe hypotension, which can cause fainting, and bradycardia, an abnormally low heart rate. Hepatic dysfunction and severe allergic reactions, including anaphylaxis, are also rare but require immediate medical attention.

Moxonidine is contraindicated in patients with known hypersensitivity to the drug, those with severe hypotension, and individuals with certain cardiac conduction disorders. Caution is also advised for patients with significant renal or hepatic impairment, and it should be avoided in pregnancy unless absolutely necessary.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxonidine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT